Your browser doesn't support javascript.
loading
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Axelrad, Jordan E; Bazarbashi, Ahmad; Zhou, James; Castañeda, Daniel; Gujral, Amandeep; Sperling, Dylan; Glass, Jason; Agrawal, Manasi; Hong, Simon; Lawlor, Garrett; Hudesman, David; Chang, Shannon; Shah, Shailja; Yajnik, Vijay; Ananthakrishnan, Ashwin; Khalili, Hamed; Colombel, Jean-Frederic; Itzkowitz, Steven.
Afiliação
  • Axelrad JE; Inflammatory Bowel Disease Center at New York University Langone Health, Division of Gastroenterology, Department of Medicine, New York University School of Medicine, New York, New York. Electronic address: Jordan.Axelrad@nyulangone.org.
  • Bazarbashi A; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Zhou J; Department of Medicine, New York University School of Medicine, New York, New York.
  • Castañeda D; Division of Gastroenterology and Hepatology, Department of Medicine, Cleveland Clinic Florida, Weston, Florida.
  • Gujral A; Crohn's and Colitis Center at Massachusetts General Hospital, Division of Gastroenterology, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sperling D; Division of Cancer Prevention and Control, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Glass J; Division of Gastroenterology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Agrawal M; Division of Gastroenterology, Department of Medicine, Lenox Hill Hospital, New York, New York.
  • Hong S; Division of Gastroenterology, Department of Medicine, Montefiore Medical Center, New York, New York.
  • Lawlor G; Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Hudesman D; Inflammatory Bowel Disease Center at New York University Langone Health, Division of Gastroenterology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Chang S; Inflammatory Bowel Disease Center at New York University Langone Health, Division of Gastroenterology, Department of Medicine, New York University School of Medicine, New York, New York.
  • Shah S; Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Yajnik V; Crohn's and Colitis Center at Massachusetts General Hospital, Division of Gastroenterology, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Ananthakrishnan A; Crohn's and Colitis Center at Massachusetts General Hospital, Division of Gastroenterology, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Khalili H; Crohn's and Colitis Center at Massachusetts General Hospital, Division of Gastroenterology, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Colombel JF; Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Itzkowitz S; Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Clin Gastroenterol Hepatol ; 18(4): 872-880.e1, 2020 04.
Article em En | MEDLINE | ID: mdl-31302306
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article